Mouse / Rat PYY ELISA

$1,274.00
Catalog
48-PYYRT-E01.1
This Mouse and Rat PYY ELISA kit is used for the quantitative determination of mouse or rat PYY in serum or edta plasma samples. There are many advantages to performing the Mouse and Rat PYY ELISA, including sensitive quantification, high specificity, no influence from other plasma components, and the needlessness of sample pretreatment. The PYY standard is a highly purified synthetic product (purity: higher than 98). The Mouse and Rat PYY ELISA kit shows 10 cross reactivity to human PYY and less than 0.01 cross reactivity to human and rat NPY, which has a similar amino acid sequence to rat PYY. Research Use Only. Not for Use in Diagnostic Procedures.
This enzyme immunoassay (EIA) kit is a stable and convenient assay system for peptide YY (PYY). PYY was isolated initially by Tatemoto et al. (1980) from the extract of pig duodenum and shown to be a polypeptide consisting of 36 amino acid residues. PYY is homologous to pancreatic polypeptide (PP) and neuropeptide Y (NPY). PYY is localized mainly in endocrine cells in the intestine (ileum, colon, and rectum) showing an inhibitory action on contraction of the gastrointestinal tract and on secretion of pancreatic and gastric juice. PYY is released by ingesting food. The PYY level decreases after resection of the intestine possibly are due to the decrease in the number of the endocrine cells secreting PYY. The EIA kit is prepared by using synthetic mouse/rat PYY (3-36) as standard antigen and biotinylated mouse/rat PYY (3-36) as labeled antigen. The kit contains specific polyclonal antibody recognized to the amino acid sequence of Mouse/rat PYY.
Species
Mouse, Rat
Regulatory Status
Research Use Only. Not for Use in Diagnostic Procedures.
Product Distribution
Available Worldwide
Range
0.15 - 12.5 ng/mL
Sensitivity
0.31 ng/mL
Sizes
96 Wells
Sample Types
EDTA Plasma, Plasma, Serum
Inc Time Overnight
No
Inc Time See Protocol
No
Sample Size
25
Detection
Colorimetric

Mouse / Rat PYY ELISA

48-PYYRT-E01.1

Billing Address

Shipping Address

Resources to advance your discoveries 

Recent posts

8 Questions to Ask Before Choosing an Allergy Testing Platform
8 Questions to Ask Before Choosing an Allergy Testing Platform
1. What percentage of your IgE allergy testing panel consists of molecular allergens rather than allergen extracts? The ALEX2 IgE allergen panel consists of 117 extracts and 183 molecular allergens. This represents the largest panel of molecular allergens on the market, including 50 unique...
View Now
Understanding IgE Allergy Test Results
Understanding IgE Allergy Test Results
Cases of food and environmental allergies have been increasing over the last decade. While conservative estimates suggest IgE-mediated allergy affects 6-8% of children and 2-3% of adults, some estimates are as high as 30%.3, 2 Symptoms can range from mild to severe and include itching, hives,...
View Now
Improving Food Elimination Diets with IgG Testing
Improving Food Elimination Diets with IgG Testing
Food sensitivity or food intolerance involves a non-allergic response to a food or food additive. In a recent on-line survey conducted in the U.S., 24% of adults aged 18 to 79 reported a food intolerance. While a food allergy is typically mediated by IgE antibodies, adverse reactions to food...
View Now

Recent posts

An End to Subjective RPR Reading?
An End to Subjective RPR Reading? Development of a Novel Automated Nontreponemal Immunoassay for Syphilis
Discover ALPCO’s novel automated nontreponemal immunoassay for syphilis testing. Reduce subjectivity, improve workflow efficiency, and support faster treatment decisions.
View Now
Variation In Calprotectin Results by Methodology
Same Sample, Different Result? What New Research Reveals About Fecal Calprotectin Variability
In a head-to-head comparison of FDA-cleared assays and a novel ALPCO method, investigators observed wide variability in specificity and false-positive rates across platforms, raising important questions about standardization and clinical interpretation.
View Now
ALPCO News
NuvinkaDx Announces Major Milestones for Portfolio Companies GeneProof and ALPCO
July 22, 2025 – Salem, NH – NuvinkaDx, a leading innovator in diagnostic solutions, today announced two significant product and regulatory milestones from its operating companies, GeneProof and ALPCO.
View Now

Biomarkers of Energy Homeostasis Brochure

Energy homeostasis is a focus of research into diabetes and obesity. Read about how our assays in this area can assist both academic and industry researchers.

Complement System Solutions for Drug Development and Clinical Research Datasheet

The complement system is essential to innate immunity from a variety of diseases. ALPCO’s full range of complement system immunoassays can drive discovery.

Melatonin Products for Sleep Disorder-Related Research Datasheet

The melatonin hormone affects the circadian rhythm and sleep-wake cycle. Find out about our immunoassays and products that explore melatonin and sleep disorders.